SAMYANG Biopharmaceuticals Overview

  • Founded
  • 2011
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

SAMYANG Biopharmaceuticals General Information


Developer of injections and medical devices designed to treat breast cancer, lung cancer and ovarian cancer. The company's injections and medical devices are made from paclitaxel and free from toxic surfactant, enabling medical professionals to treat breast cancer, lung cancer, prostate cancer and ovarian cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Therapeutic Devices
Other Industries
Drug Delivery
Primary Office
  • 295, Pangyo-ro, Bundang-gu
  • Seongnam-si, Gyeonggi-do
  • South Korea
+82 00-0000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SAMYANG Biopharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 17-Mar-2016 Completed Generating Revenue
To view SAMYANG Biopharmaceuticals’s complete valuation and funding history, request access »

SAMYANG Biopharmaceuticals Executive Team (3)

Name Title Board Seat Contact Info
Uhm Tae-Woong President
You’re viewing 1 of 3 executive team members. Get the full list »

SAMYANG Biopharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
KIC Europe Accelerator/Incubator 000 0000 000000 0
To view SAMYANG Biopharmaceuticals’s complete investors history, request access »